{"protocolSection":{"identificationModule":{"nctId":"NCT01541163","orgStudyIdInfo":{"id":"NT 11046-6/2010"},"secondaryIdInfos":[{"id":"Grant project No.86-17","type":"OTHER","domain":"University Hospital Olomouc"}],"organization":{"fullName":"University Hospital Olomouc","class":"OTHER"},"briefTitle":"Heart and Ischemic STrOke Relationship studY","officialTitle":"Assessment of Relationship Between Acute Ischemic Stroke and Heart Disease","acronym":"HISTORY"},"statusModule":{"statusVerifiedDate":"2017-10","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2010-09"},"primaryCompletionDateStruct":{"date":"2018-06","type":"ESTIMATED"},"completionDateStruct":{"date":"2018-11","type":"ESTIMATED"},"studyFirstSubmitDate":"2012-02-23","studyFirstSubmitQcDate":"2012-02-28","studyFirstPostDateStruct":{"date":"2012-02-29","type":"ESTIMATED"},"lastUpdateSubmitDate":"2017-10-31","lastUpdatePostDateStruct":{"date":"2017-11-01","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Michal Kral","investigatorTitle":"Study Director","investigatorAffiliation":"University Hospital Olomouc"},"leadSponsor":{"name":"University Hospital Olomouc","class":"OTHER"},"collaborators":[{"name":"Ministry of Health, Czech Republic","class":"OTHER_GOV"},{"name":"Palacky University","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Although cardio-embolic etiology of ischemic stroke (IS) is largely respected, there is still no clear recommendation for routine complex cardiological examination in all IS patients. Using complex cardiological examination the investigators expect:\n\n1. more accurate detection of patients with concomitant heart disease (cardiac rhythm disorder, valve disorders, acute coronary syndrome, cardiac thrombus and myxoma, atrial and ventricle septum defects)\n2. higher number of etiologically determinated IS, which is crucial for accurate secondary prevention.","detailedDescription":"The investigators expect significant changes of biochemical parameters (NT pro B-type of natriuretic peptide, pro-atrial natriuretic peptide, creatinkinase MB, troponin T), inflammatory markers (interleukine 6, procalcitonin, high sensitive C-reactive protein), and coagulation parameters in patients with CE IS compared to other causes of IS.\n\nAssessing the glomerular filtration of cystatin C, glycated haemoglobin and serum lipids and its correlation with prior medicament use will allow to evaluate the long-term compensation of arterial hypertension, diabetes mellitus and dyslipidemia in IS patients.\n\nIn addition to the above mentioned comprehensive cardiological examinations, 1- and 3-week ECG-Holter will be performed in subpopulation of patients old up to 50 years and with cryptogenic ischemic stroke in the period from 1st May 2013 to 31st December 2015. These patients will also fill in a special epidemiologic questionnaire. Anticipated enrollment in this substudy of HISTORY study is 40 - 80 patients.\n\nIn selected young cryptogenic stroke patients, a subcutaneous cardiac monitor was implanted for the detection of paroxysmal atrial fibrillation in the period from 1st January 2014 to 31st December 2015.\n\nFrom 2016 in young ischemic stroke (IS) patients under 50 years, a standard perfusion/ventilation scintigraphy of lungs will be performed to exclude acute pulmonary embolization (coincidental) in case of elevated serum D-dimers after admission.\n\nIn all enrolled young IS patients, a BP Holter will be performed after the discharge home to exclude possible arterial hypertension, which did not presented during hospitalization."},"conditionsModule":{"conditions":["Brain Ischemia","Acute Stroke","Heart Diseases"],"keywords":["Ischemia","Brain Infarction","Acute Stroke","Heart Diseases","Myocardial Infarction"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":500,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Acute Ischemic Stroke","description":"Patients with acute ischemic stroke admitted within 12 hours after onset."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"To assess the serum level profile of cardiac troponin T (cTnT) in acute ischemic stroke (AIS) patients and to evaluate factors associated with increased serum level of cTnT.","timeFrame":"Within 12 hours after ischemic stroke onset."}],"secondaryOutcomes":[{"measure":"Correlation between location and volume of brain infarction.","timeFrame":"At admission within 12 hours after stroke onset and after 24hours."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ischemic stroke admitted within 12 hours from stroke onset at stroke center\n\nExclusion Criteria:\n\n* none","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"],"studyPopulation":"Consecutive ischemic stroke patients within 12 hours from stroke onset, who will be admitted at Comprehensive Stroke Center, Department of Neurology, University Hospital Olomouc from the October 2010 until December 2015.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Michal Kral, MD","role":"CONTACT","phone":"+420 604 171 594","email":"michal.kral@fnol.cz"}],"overallOfficials":[{"name":"Michal Kral, MD","affiliation":"University Hospital Olomouc","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"University Hospital Olomouc","status":"RECRUITING","city":"Olomouc","zip":"775 20","country":"Czechia","contacts":[{"name":"Michal Kral, MD","role":"CONTACT","phone":"+420 604 171 594","email":"michal.kral@fnol.cz"},{"name":"Michal Kral, MD","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Daniel Sanak, MD,PhD","role":"SUB_INVESTIGATOR"},{"name":"Tomas Veverka, MD.","role":"SUB_INVESTIGATOR"},{"name":"David Skoloudik, MD,PhD,prof.","role":"SUB_INVESTIGATOR"},{"name":"Roman Herzig, MD,PhD,prof.","role":"SUB_INVESTIGATOR"},{"name":"Andrea Bartkova, MD., PhD.","role":"SUB_INVESTIGATOR"},{"name":"Martin Hutyra, MD., PhD.","role":"SUB_INVESTIGATOR"},{"name":"David Vindis, MD.","role":"SUB_INVESTIGATOR"},{"name":"Petr Kanovsky, MD,PhD,prof.","role":"SUB_INVESTIGATOR"},{"name":"Anna Kuncarova","role":"SUB_INVESTIGATOR"},{"name":"Milos Taborsky, MD,PhD,prof.","role":"SUB_INVESTIGATOR"},{"name":"Tomas Skala, MD, PhD.","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":49.59552,"lon":17.25175}}]},"referencesModule":{"references":[{"pmid":"34623123","type":"DERIVED","citation":"Franc D, Sanak D, Divisova P, Lyskova L, Bartkova A, Zapletalova J, Kral M, Dornak T, Polidar P, Veverka T, Kanovsky P. Socioeconomic status and lifestyle in young ischaemic stroke patients: a possible relationship to stroke recovery and risk of recurrent event. Cent Eur J Public Health. 2021 Sep;29(3):223-229. doi: 10.21101/cejph.a6697."},{"pmid":"32912364","type":"DERIVED","citation":"Divisova P, Sanak D, Vaclavik J, Kral M, Hutyra M, Zapletalova J, Bartkova A, Franc D, Dornak T, Veverka T, Taborsky M, Kanovsky P. Arterial Hypertension and Risk of Recurrent Event in Young Ischemic Stroke Patients. Can J Neurol Sci. 2021 May;48(3):358-364. doi: 10.1017/cjn.2020.200. Epub 2020 Sep 11."},{"pmid":"32807456","type":"DERIVED","citation":"Divisova P, Sanak D, Kral M, Bartkova A, Hutyra M, Zapletalova J, Dornak T, Spacek M, Franc D, Polidar P, Veverka T, Kanovsky P. Young cryptogenic ischemic stroke: A descriptive analysis of clinical and laboratory characteristics, outcomes and stroke recurrence. J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105046. doi: 10.1016/j.jstrokecerebrovasdis.2020.105046. Epub 2020 Jun 23."},{"pmid":"32563078","type":"DERIVED","citation":"Sanak D, Divisova P, Hutyra M, Kral M, Bartkova A, Zapletalova J, Latal J, Dornak T, Hudec S, Franc D, Polidar P, Veverka T, Kanovsky P. Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source. J Neurol Sci. 2020 Sep 15;416:116985. doi: 10.1016/j.jns.2020.116985. Epub 2020 Jun 13."},{"pmid":"25916280","type":"DERIVED","citation":"Sanak D, Hutyra M, Kral M, Bartkova A, Zapletalova J, Fedorco M, Veverka T, Vindis D, Dornak T, Skala T, Skoloudik D, Taborsky M, Kanovsky P. Paroxysmal atrial fibrillation in young cryptogenic ischemic stroke: A 3-week ECG Holter monitoring study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):283-7. doi: 10.5507/bp.2015.019. Epub 2015 Apr 24."},{"pmid":"25573455","type":"DERIVED","citation":"Sanak D, Hutyra M, Kral M, Bartkova A, Zapletalova J, Fedorco M, Veverka T, Vindis D, Dornak T, Skala T, Skoloudik D, Taborsky M, Kanovsky P. Atrial fibrillation in young ischemic stroke patients: an underestimated cause? Eur Neurol. 2015;73(3-4):158-63. doi: 10.1159/000369793. Epub 2015 Jan 8."},{"pmid":"25497535","type":"DERIVED","citation":"Kral M, Sanak D, Veverka T, Hutyra M, Vindis D, Bartkova A, Kuncarova A, Dornak T, Cechakova E, Herzig R, Langova K, Kanovsky P, Skoloudik D. Troponin T: Correlation with location and volume of acute brain infarction. Int J Cardiol. 2015 Feb 15;181:127-32. doi: 10.1016/j.ijcard.2014.12.027. Epub 2014 Dec 3."},{"pmid":"23069890","type":"DERIVED","citation":"Kral M, Skoloudik D, Sanak D, Veverka T, Bartkova A, Dornak T, Hutyra M, Vindis D, Ulehlova J, Slavik L, Svabova M, Kubickova V, Herzig R, Kanovsky P. Assessment of relationship between acute ischemic stroke and heart disease--protocol of a prospective observational trial. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):284-9. doi: 10.5507/bp.2012.094. Epub 2012 Oct 4."}],"seeAlsoLinks":[{"label":"University Hospital Olomouc","url":"http://www.fnol.cz/"},{"label":"Ministry of Health of Czech Republic","url":"http://www.mzcr.cz/"},{"label":"Biomedical Papers - Protocol of a prospective observational trial","url":"http://biomed.papers.upol.cz/pdfs/bio/2012/03/16.pdf"},{"label":"Kral M et al. Troponin T in Acute Ischemic Stroke. Am J Cardiol. 2013 Jul 1;112(1):117-21. Epub 2013 Apr 6.","url":"http://www.ncbi.nlm.nih.gov/pubmed/23566538"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14","removedCountries":["Czech Republic"]},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M11845","name":"Myocardial Infarction","relevance":"LOW"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","asFound":"Brain Ischemia","relevance":"HIGH"},{"id":"M9109","name":"Heart Diseases","asFound":"Heart Disease","relevance":"HIGH"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}